Skip to main content
VCbacked
Log inGet Started

Ancilia Biosciences

New York, United States

Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.

$4.2M raised
Apr 2026
Venture - Series Unknown
BiotechnologyHealth CareLife Science

Top Investors

National Science FoundationSafar PartnersMetaplanetSpacecadet VenturesPsyMed Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ancilia Biosciences

How much funding has Ancilia Biosciences raised?
Ancilia Biosciences has raised $4.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Ancilia Biosciences's investors?
Ancilia Biosciences's investors include National Science Foundation, Safar Partners, Metaplanet, Spacecadet Ventures, PsyMed Ventures.
Where is Ancilia Biosciences headquartered?
Ancilia Biosciences is headquartered in New York, United States.
What does Ancilia Biosciences do?
Ancilia Biosciences offers bacterial therapeutics that address the microbiome's viral components.
What stage is Ancilia Biosciences at?
Ancilia Biosciences is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Ancilia Biosciences — Funding & Investors." VCBacked, April 6, 2026, https://www.vcbacked.co/company/ancilia-biosciences. Accessed June 4, 2026.
APA
VCBacked. (2026). Ancilia Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/ancilia-biosciences
Wikipedia (cite web)
{{cite web |title=Ancilia Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/ancilia-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong